发明名称 MOLECULE WITH EXTENDED HALF-LIFE, AND COMPOSITION AND USE THEREOF
摘要 <P>PROBLEM TO BE SOLVED: To provide molecules with extended in vivo half-lives by modification of an IgG constant domain or a domain thereof that binds FcRn (Fc Receptor-neonate). <P>SOLUTION: There are provided molecules including IgGs, non-IgG immunoglobulins, proteins and non-protein substances that have extended in vivo half-lives due to the presence of an IgG constant domain to FcRn, or a portion thereof that binds the FcRn, having one or more amino acid modifications that increase the affinity of the IgG constant domain or fragment for FcRn. Such proteins and molecules with increased half-lives have the advantage that smaller amounts and/or less frequent dosing is required in the therapeutic, prophylactic or diagnostic use of such molecules. <P>COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2010154855(A) 申请公布日期 2010.07.15
申请号 JP20100000073 申请日期 2010.01.04
申请人 MEDIMMUNE LLC;BOARD OF REGENTS THE UNIV OF TEXAS SYSTEM 发明人 DALL ACQUA WILLIAM;JOHNSON LESLIE S;WARD ELIZABETH SALLY
分类号 C12N15/09;G01N33/534;A61K38/00;A61K39/00;A61K39/395;A61K47/48;A61K49/00;A61P11/00;A61P31/12;A61P31/16;A61P37/00;C07K14/705;C07K16/00;C07K16/08;C07K16/18;C07K16/46;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10 主分类号 C12N15/09
代理机构 代理人
主权项
地址